Add BrightSurf on Google Email

Science News for January 31, 2002


Cells on the verge of suicide

A team of researchers has identified the entire series of proteins that relay a message of survival from a neuron to a glial cell in the fruit fly Drosophila melanogaster, shedding light on how cells 'know' whether to survive or perish. This discovery may lead to novel treatments for diseases such as Alzheimer's and cancer.

SourceRockefeller University·JournalDevelopmental Cell·DateJan 31, 2002

Tidying up transcription factors

Researchers James E. Darnell and Ali H. Brivanlou propose a reclassification of all known transcription factors, grouping them by their behavior rather than physical structure. This framework aims to provide a better understanding of how cells 'read' genetic instructions and may lead to new drug therapies for diseases such as cancer an...

SourceRockefeller University·JournalScience·DateJan 31, 2002

E. coli bacteria make Alzheimer’s-linked fibers

Certain strains of E. coli produce amyloid fibers similar to those found in Alzheimer's disease, forming a meshwork around the bacteria in biofilms. This discovery raises questions about the role of bacterial infections in amyloid diseases, including Alzheimer's, and may lead to new treatment options.

SourceWashU Medicine·JournalScience·DateJan 31, 2002

Pheromones control sex discrimination in mice

Researchers have found that pheromones play a crucial role in mice's gender recognition. The knockout mice, which lacked a gene for a pheromone receptor, were unable to recognize males and displayed unusual mating behavior. This breakthrough provides new insights into the neural circuitry responsible for sex discrimination in mice.

Mammography screening-the debate continues

A recent meta-analysis and follow-up study found no immediate life-saving effect of mammography screening, but suggested that it may reduce breast cancer mortality after several years. Researchers argue that the analysis must focus on case-fatality rates rather than overall mortality rates to accurately evaluate the benefits.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 31, 2002